On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. | Front Pharmacol;10: 1664, 2019. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Localizar descritor de assunto Busca Avançada

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients.

Verbaanderd, Ciska; Rooman, Ilse; Meheus, Lydie; Huys, Isabelle.

Afiliação

Verbaanderd C; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Rooman I; Anticancer Fund, Strombeek-Bever, Belgium.
Meheus L; Anticancer Fund, Strombeek-Bever, Belgium.
Huys I; Oncology Research Centre, Vrije Universiteit Brussel, Brussels, Belgium.

Front Pharmacol ; 10: 1664, 2019.

Article em En | MEDLINE | ID: mdl-32076405

Palavras-chave

drug repositioning; drug repurposing; incentives; off-label use; oncology; policy; regulatory framework

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Health_technology_assessment Idioma: En Ano de publicação: 2019 Tipo de documento: Article